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Abstract: The degree and characteristic of airway inflammation were evaluated by the
proportions of bronchoalveolar lavage (BAL) cells. CI inical asthma types such as I a.
simple bronchoconstriction, I b. bronchoconstriction + hypersecretion, and II. bron-
chiolar obstruction correlate with airway inflammation. The increased proportion BAL
neutrophils is characteristic of type II asthma, and increase in BAL eosinophil count
is often observed in type I b asthma. Bronchial hyperresponsiveness also correlates
with airway inflammation.
Action of spa therapy has been speculated to be related to airway inflammation,
since the therapy has no action inhibiting IgE-mediated allergic reaction. In fact, spa
therapy is more effective in patients with type I b and type II than in those with
type I a showing slight degree of airway inflammation. Bronchial hyperresponsiveness
is also improved by spa therapy. From a point of view, the direct action of spa
therapy may be to clean airways and improve damaged mucous membrane of the
airways, leading to suppression of airway inflammation.
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Introduction
The symptoms of asthma are associated
with such pathophysiological changes of the
aIrways as bronchoconstriction, bronchial
wall edema, and mucus hypersecretion. In
addition to these pathophysiological changes,
bronchiolar obstruction is clinically observed
during asthma attacks I, 2), and this is specu-
lated to related inflammatory cell infiltra-
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Clinical asthma type
patients with atopic asthma (r= - 0.67,
Bronchial asthma is classified into three
types; I a. simple bronchoconstriction type,
lb. bronchoconstriction +hypersecretion type
Fig. 1. Correlation between bronchial reac-
tivity and proportion of eosinophils
in BAL fluid in patients with atopic
asthma (r= -0.67, p<0.05).
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correlation was found III atopic subjects
between the proportion of combined eos-
inophils (Eos) and neutrophils (Neut) and
bronchial reactivity (BR) (r= - 0.71, P<
0.05) compared with that between the propor-
tion of BAL eosinophils and BR (Fig. 2). In
nonatopic asthmatics, a correlation between
the proportion of BAL eosinophils and BR
was also found (r= -0.51, p<0.05) (Fig. 3).
There was, however, no correlation between
the proportion of Eos + Neut in BAL fluid
and BR. These results suggest that
neutrophils as well as eosinophils participate
in increase of bronchial responsiveness. An
increased number of neutrophils in BAL fluid
has been reported in patients with asthma 18) ,
Furthermore, some reports suggest participa-
tion of neutrophils in bronchial hyperres-
ponsiveness la 20) •
Airway inflammation and bronchial
responsiveness
Bronchial hyperresponsiveness IS closely
related to airway inflammations, 13-16). The
correlation between the proportion of each
type of BAL cells and bronchial hyperre-
sponsiveness was examined in our previous
study, by measuring bronchial reactivity to
methacholine 17). A significant correlation
between the proportion of BAL eosinophils
and bronchial reactivity was observed in
tion of small airways. In the onset mecha-
nisms of asthma, humoral factors such as
histamine and leukotrienes in the early stage
of asthma attacks OAR; immediate asth-
matic reaction) 3-6), and cellular components
such as lymphocytes, neutrophils, eosinophils,
and basophils in the late stage (LAR; late
asthmatic reaction) have been shown to play
important roles 7~9). Thus, airway inflamma-
tion accompanied with blood cell migration
into allergic reaction sites is now considered
to be a common pathological feature in
asthma, particularly in the LAR 10-12). Bron-
chial hyperresponsiveness is characteristic of
patients with bronchial asthma. Airway
inflammation is closely related to bronchial
hyperresponsiveness.
Spa therapy is expected to improve late
asthmatic reaction (LAR) accompanied with
airway inflammation, but not to inhibit
early stage of asthma attacks (humoral
phase) OAR) by IgE-mediated allergic reac-
tion. Spa therapy also improves bronchial
hyperresponsiveness. In this article, a correla-
tion between spa effects and airway inflam-
mation was discussed in relation to effects of
the therapy associated with the proportions
of BAL cells and bronchial reactivity to
methacholine.
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Fig. 2. Correlation between bronchial
reactivity and proportion of
eosinophils + neutrophils in BAL
fluid in patients with atopic asthma
(r=-0.71, p<0.05).
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asthma III general requires a long-term
glucocorticoid therapy, leading to suppression
of humoral and cellular immunity 25, 26). It is
not clear whether an increase in the propor-
tion of BAL neutrophils associated with
suppressed immunity in type II asthma corre-
lates with bronchial hyperresponsiveness.
Thus, BAL neutrophilia is often observed in
type II asthma, however, type II asthma
without BAL neutrophilia has been found in
our recent studies m. The proportion of
eosinophils in BAL fluid, being closely related
to hypersecretion in the airways 28), is higher
in patients with type I a - 2 , type lb and
type II than in those with the other types of
asthma (Fig. 4).
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Fig. 3. Correlation between bronchial reac-
tivity and proportion of eosinophils
III BAL fluid III patients with
nonatopic asthma(r= -0.51, p<0.05).
(expectoration more than 100 mP/day), and
II. bronchiolar obstruction type, according to
clinical symptoms. 21-24). Type I a is, further-
more, divided into two subtypes according to
expectoration per day; la-1 (0-49mP/
day) and la-2 (50-99mP/day).
There is a peculiar finding in the BAL cells
regarding the proportion of neutrophils. The
proportion of BAL neutrophils is signifi-
cantly higher in type II than in the other
types of asthma. Patients with type II
Asthma type
Fig. 4. Proportion of neutrophils (. ) and
eosinophils ( ~ ) in the BAL fluid
of patients with each clinical type
of asthma. a, b, c, d, and f p<O.OOl,
e, p<0.02
Spa efficacy and asthma type
Spa efficacy is different among three clini-
cal asthma types, in our study on spa effi-
cacy for each asthma type of 136 patients
with asthma, the efficacy rate was 76.4%
I b patients with simple bronchoconstriction
(type I a), 82.6% in those with bronchocon-
striction + hypersecretion (type I b), and
88.9% in those with bronchiolar obstruction
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Spa therapy in patients with SOIA
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Fig. 6. Reduction of expectoration by spa
therapy in asthmatic patients with
expectoration over 100mi!/day under
the age of 59 (~) and in those
over age 60 (0-0).
Despite newly developed antiasthma drugs
including antiallergic agents, sometimes phy-
sicians have a difficult task to treatment
asthma attacks. There are some patients
Fig. 5. Effects of spa therapy on airway
mucus hypersecretion in asthmatic
patients with expectoration over
100mi!/day. ·p<0.05, ··p<0.02,
···p<O.Ol
(type II) 29), showing that the efficacy rate
was the highest in type II and the lowest in
type I a. Type II asthma is always accom-
panied with obstruction of small airways, for
which any antiasthma drugs except glucoco-
rticoids are not effective. Spa efficacy for
the pathophysiological changes of small
airways is one of the most important role of
the therapy:lJ).
Spa therapy suppresses hypersecretion of
the airways in patients with asthma. In our
previous studies on asthma patients with
expectoration over 100 mi! / day, the volume
of expectoration before spa therapy C163mi!/
day) was significantly reduced to 56m1!/day
after 2 -week spa therapy (p<O.Ol) 31) •
A significant reduction was also observed
after 4 -, 5 -, 6 -, and 7 -week spa therapy.
although the volume of expectoration tended
to increase 3 weeks after the therapy (Fig.
5). In terms of patient age, in those over
the age of 60 with expectoration over 100mi!
/ day, the volume decreased more rapidly and
to a greater extent in those under age 59
with this volume of expectoration. However,
this difference between the two age groups
was not significant (Fig. 6). These results
suggest that spa therapy is more effective in
asthma patients in whom airway inflamma-
tion is clearly observed than in those with
slight airway inflammation and in those
whose attacks are mainly induced by immedi-
ate allergic reaction.
Patients with type I b and type II asthma
tend to require long-term glucocorticoid
regimen. In fact, majority of these patients
has steroid-dependent intractable asthma
(SDIA) Requirement of· spa therapy for
bronchial asthma is larger III patients with
these types of asthma.
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whose symptoms can not be controlled by
usual medications except glucocorticoids.
Their attacks often begin to occur at middle
age (so-called late onset asthma). Shortly
after their attacks begin to occur, glucoco-
rticoid therapy is required to control their
attacks, leading to SDIA.
An important role of spa therapy is to
have particular advantage in the treatment
for patients with SDIA IH6). The therapy has
direct and indirect effects on bronchial
asthma. The dysfunction of airways, espe-
cially small airways, is improved by the
direct action of spa therapy. In the indirect
action of spa therapy '5I.:JIl) , improvement of
suppressed function of adrenocortical glands
can be observed. The action is one of the
most important roles of spa therapy for
bronchial asthma, since the suppression of
adrenocortical glands function is observed in
the majority of these patients with SDIA.
Thus, it has been expected that spa therapy
acts effectively on bronchial asthma to nor-
malize the function of airways and adren-
ocortical glands.
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気管支唱息に対する複合温泉療法の作用機序
3.気道炎症反応との関連
岡山大学医学部附属病院三朝分院内科,I)医学部
臨床検査医学
保崎泰弘,御船尚志,光延文裕,芦田耕三,
横田 聡,柘野浩史,竹内一昭,名和由一郎,
谷崎勝朗,1)越智浩二,1)原田英雄,
気道炎症反応の程度や特徴が,気管支肺胞洗浄
液 (BAL)中の細胞成分によって評価された｡
Ia.単純性気管支撃縮型,Ib.気管支撃縮+過
分泌型,Ⅱ.細気管支閉塞型などの各臨床病型は
気道炎症反応と関連している｡BAL液中好中球
増多は,Ⅱ型喋息の特徴的所見であり,また好酸
球増多はIb型鳴息でしばしば観察される｡気道過
敏性もまた気道炎症反応と関連している｡
温泉療法の作用機序としては,温泉療法にIgE
にmediateされるアレルギー反応 (液性因子相)
を抑制する作用がないことから,気道炎症反応
(細胞性因子相)の抑制が推測されている｡実際,
温泉療法は,気道炎症反応が軽度なIa型喋息に
比べ,Ib型やⅡ型などの明らかに気道炎症反応
をともなう病型に対してより有効である｡気道過
敏性もまた温泉療法により改善される｡これらの
結果から,温泉療法は,気道を清浄化し,気道粘
膜を正常化することによって,気道炎症反応を抑
制していくものと考えられる｡
索引用語 :温泉療法,気道炎症反応,BAL好酸球
増多,BAL好中球増多,気管支瑞息
